Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions

Szilvia Erdélyi-Bótor, Hedvig Komáromy, David Olayinka Kamson, Norbert Kovács, Gábor Perlaki, Gergely Orsi, Tihamér Molnár, Zsolt Illes, Lajos Nagy, Sándor Kéki, Gabriella Deli, Edit Bosnyák, Anita Trauninger, Zoltán Pfund

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

BACKGROUND/AIM: Migraine is a risk factor for the formation of silent brain white matter lesions (WMLs) that are possibly ischemic in nature. Although dysfunction of the L-arginine/nitric oxide (NO) pathway has been associated with oxidative stress and endothelial dysfunction in migraine, its role in WML development has not been specifically investigated. Thus, this prospective study aimed to measure the serum concentrations of the NO substrate L-arginine, the NO synthase inhibitor asymmetric dimethylarginine (ADMA), and the L-arginine transport regulator symmetric dimethylarginine (SDMA) in migraine patients in a headache-free period.

METHODS: All participants underwent MR imaging to assess for the presence of WMLs on fluid-attenuated inversion recovery imaging. Altogether 109 migraine patients (43 with lesions, 66 without lesions) and 46 control individuals were studied. High-performance liquid chromatography was used to quantify L-arginine, ADMA and SDMA serum concentrations. Migraine characteristics were investigated, and participants were screened for risk factors that can lead to elevated serum ADMA levels independent of migraine.

RESULTS: Migraine patients and controls did not differ in regard to vascular risk factors. Migraineurs with WMLs had a longer disease duration (p < 0.001) and a higher number of lifetime headache attacks (p = 0.005) than lesion-free patients. Higher L-arginine serum levels were found in both migraine subgroups compared to controls (p < 0.001). Migraine patients with WMLs showed higher ADMA concentrations than lesion-free patients and controls (p < 0.001, for both). In migraineurs, the presence of WMLs, aura and increasing age proved to be significant predictors of increased ADMA levels (p = 0.008, 0.047 and 0.012, respectively). SDMA serum levels of lesional migraineurs were higher than in nonlesional patients (p < 0.001). The presence of lesions and increasing age indicated an increased SDMA level (p = 0.017 and 0.001, respectively). Binary logistic regression analysis showed that ADMA level (p = 0.006), increasing age (p = 0.017) and the total number of lifetime migraine attacks (p = 0.026) were associated with an increased likelihood of exhibiting WMLs. There was no significant effect of age on ADMA and SDMA concentrations in controls.

CONCLUSIONS: Elevated ADMA levels may impact the pathogenesis of migraine-related WMLs by influencing cerebrovascular autoregulation and vasomotor reactivity. Higher SDMA concentrations may indirectly influence NO synthesis by reducing substrate availability. Elevated L-arginine serum levels might reflect an increased demand for NO synthesis.

Original languageEnglish
JournalCephalalgia
Volume37
Issue number6
Pages (from-to)571-580
ISSN0333-1024
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Serum
White Matter
Nitric Oxide Synthase
N,N'-dimethylarginine
Nitric Oxide
Homeostasis
Logistic Models
High Pressure Liquid Chromatography
Regression Analysis
Prospective Studies

Cite this

Erdélyi-Bótor, S., Komáromy, H., Kamson, D. O., Kovács, N., Perlaki, G., Orsi, G., ... Pfund, Z. (2017). Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions. Cephalalgia, 37(6), 571-580. https://doi.org/10.1177/0333102416651454
Erdélyi-Bótor, Szilvia ; Komáromy, Hedvig ; Kamson, David Olayinka ; Kovács, Norbert ; Perlaki, Gábor ; Orsi, Gergely ; Molnár, Tihamér ; Illes, Zsolt ; Nagy, Lajos ; Kéki, Sándor ; Deli, Gabriella ; Bosnyák, Edit ; Trauninger, Anita ; Pfund, Zoltán. / Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions. In: Cephalalgia. 2017 ; Vol. 37, No. 6. pp. 571-580.
@article{cd28a7f70f684df1966450f687e19227,
title = "Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions",
abstract = "BACKGROUND/AIM: Migraine is a risk factor for the formation of silent brain white matter lesions (WMLs) that are possibly ischemic in nature. Although dysfunction of the L-arginine/nitric oxide (NO) pathway has been associated with oxidative stress and endothelial dysfunction in migraine, its role in WML development has not been specifically investigated. Thus, this prospective study aimed to measure the serum concentrations of the NO substrate L-arginine, the NO synthase inhibitor asymmetric dimethylarginine (ADMA), and the L-arginine transport regulator symmetric dimethylarginine (SDMA) in migraine patients in a headache-free period.METHODS: All participants underwent MR imaging to assess for the presence of WMLs on fluid-attenuated inversion recovery imaging. Altogether 109 migraine patients (43 with lesions, 66 without lesions) and 46 control individuals were studied. High-performance liquid chromatography was used to quantify L-arginine, ADMA and SDMA serum concentrations. Migraine characteristics were investigated, and participants were screened for risk factors that can lead to elevated serum ADMA levels independent of migraine.RESULTS: Migraine patients and controls did not differ in regard to vascular risk factors. Migraineurs with WMLs had a longer disease duration (p < 0.001) and a higher number of lifetime headache attacks (p = 0.005) than lesion-free patients. Higher L-arginine serum levels were found in both migraine subgroups compared to controls (p < 0.001). Migraine patients with WMLs showed higher ADMA concentrations than lesion-free patients and controls (p < 0.001, for both). In migraineurs, the presence of WMLs, aura and increasing age proved to be significant predictors of increased ADMA levels (p = 0.008, 0.047 and 0.012, respectively). SDMA serum levels of lesional migraineurs were higher than in nonlesional patients (p < 0.001). The presence of lesions and increasing age indicated an increased SDMA level (p = 0.017 and 0.001, respectively). Binary logistic regression analysis showed that ADMA level (p = 0.006), increasing age (p = 0.017) and the total number of lifetime migraine attacks (p = 0.026) were associated with an increased likelihood of exhibiting WMLs. There was no significant effect of age on ADMA and SDMA concentrations in controls.CONCLUSIONS: Elevated ADMA levels may impact the pathogenesis of migraine-related WMLs by influencing cerebrovascular autoregulation and vasomotor reactivity. Higher SDMA concentrations may indirectly influence NO synthesis by reducing substrate availability. Elevated L-arginine serum levels might reflect an increased demand for NO synthesis.",
author = "Szilvia Erd{\'e}lyi-B{\'o}tor and Hedvig Kom{\'a}romy and Kamson, {David Olayinka} and Norbert Kov{\'a}cs and G{\'a}bor Perlaki and Gergely Orsi and Tiham{\'e}r Moln{\'a}r and Zsolt Illes and Lajos Nagy and S{\'a}ndor K{\'e}ki and Gabriella Deli and Edit Bosny{\'a}k and Anita Trauninger and Zolt{\'a}n Pfund",
note = "{\circledC} International Headache Society 2016.",
year = "2017",
doi = "10.1177/0333102416651454",
language = "English",
volume = "37",
pages = "571--580",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications",
number = "6",

}

Erdélyi-Bótor, S, Komáromy, H, Kamson, DO, Kovács, N, Perlaki, G, Orsi, G, Molnár, T, Illes, Z, Nagy, L, Kéki, S, Deli, G, Bosnyák, E, Trauninger, A & Pfund, Z 2017, 'Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions', Cephalalgia, vol. 37, no. 6, pp. 571-580. https://doi.org/10.1177/0333102416651454

Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions. / Erdélyi-Bótor, Szilvia; Komáromy, Hedvig; Kamson, David Olayinka; Kovács, Norbert; Perlaki, Gábor; Orsi, Gergely; Molnár, Tihamér; Illes, Zsolt; Nagy, Lajos; Kéki, Sándor; Deli, Gabriella; Bosnyák, Edit; Trauninger, Anita; Pfund, Zoltán.

In: Cephalalgia, Vol. 37, No. 6, 2017, p. 571-580.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions

AU - Erdélyi-Bótor, Szilvia

AU - Komáromy, Hedvig

AU - Kamson, David Olayinka

AU - Kovács, Norbert

AU - Perlaki, Gábor

AU - Orsi, Gergely

AU - Molnár, Tihamér

AU - Illes, Zsolt

AU - Nagy, Lajos

AU - Kéki, Sándor

AU - Deli, Gabriella

AU - Bosnyák, Edit

AU - Trauninger, Anita

AU - Pfund, Zoltán

N1 - © International Headache Society 2016.

PY - 2017

Y1 - 2017

N2 - BACKGROUND/AIM: Migraine is a risk factor for the formation of silent brain white matter lesions (WMLs) that are possibly ischemic in nature. Although dysfunction of the L-arginine/nitric oxide (NO) pathway has been associated with oxidative stress and endothelial dysfunction in migraine, its role in WML development has not been specifically investigated. Thus, this prospective study aimed to measure the serum concentrations of the NO substrate L-arginine, the NO synthase inhibitor asymmetric dimethylarginine (ADMA), and the L-arginine transport regulator symmetric dimethylarginine (SDMA) in migraine patients in a headache-free period.METHODS: All participants underwent MR imaging to assess for the presence of WMLs on fluid-attenuated inversion recovery imaging. Altogether 109 migraine patients (43 with lesions, 66 without lesions) and 46 control individuals were studied. High-performance liquid chromatography was used to quantify L-arginine, ADMA and SDMA serum concentrations. Migraine characteristics were investigated, and participants were screened for risk factors that can lead to elevated serum ADMA levels independent of migraine.RESULTS: Migraine patients and controls did not differ in regard to vascular risk factors. Migraineurs with WMLs had a longer disease duration (p < 0.001) and a higher number of lifetime headache attacks (p = 0.005) than lesion-free patients. Higher L-arginine serum levels were found in both migraine subgroups compared to controls (p < 0.001). Migraine patients with WMLs showed higher ADMA concentrations than lesion-free patients and controls (p < 0.001, for both). In migraineurs, the presence of WMLs, aura and increasing age proved to be significant predictors of increased ADMA levels (p = 0.008, 0.047 and 0.012, respectively). SDMA serum levels of lesional migraineurs were higher than in nonlesional patients (p < 0.001). The presence of lesions and increasing age indicated an increased SDMA level (p = 0.017 and 0.001, respectively). Binary logistic regression analysis showed that ADMA level (p = 0.006), increasing age (p = 0.017) and the total number of lifetime migraine attacks (p = 0.026) were associated with an increased likelihood of exhibiting WMLs. There was no significant effect of age on ADMA and SDMA concentrations in controls.CONCLUSIONS: Elevated ADMA levels may impact the pathogenesis of migraine-related WMLs by influencing cerebrovascular autoregulation and vasomotor reactivity. Higher SDMA concentrations may indirectly influence NO synthesis by reducing substrate availability. Elevated L-arginine serum levels might reflect an increased demand for NO synthesis.

AB - BACKGROUND/AIM: Migraine is a risk factor for the formation of silent brain white matter lesions (WMLs) that are possibly ischemic in nature. Although dysfunction of the L-arginine/nitric oxide (NO) pathway has been associated with oxidative stress and endothelial dysfunction in migraine, its role in WML development has not been specifically investigated. Thus, this prospective study aimed to measure the serum concentrations of the NO substrate L-arginine, the NO synthase inhibitor asymmetric dimethylarginine (ADMA), and the L-arginine transport regulator symmetric dimethylarginine (SDMA) in migraine patients in a headache-free period.METHODS: All participants underwent MR imaging to assess for the presence of WMLs on fluid-attenuated inversion recovery imaging. Altogether 109 migraine patients (43 with lesions, 66 without lesions) and 46 control individuals were studied. High-performance liquid chromatography was used to quantify L-arginine, ADMA and SDMA serum concentrations. Migraine characteristics were investigated, and participants were screened for risk factors that can lead to elevated serum ADMA levels independent of migraine.RESULTS: Migraine patients and controls did not differ in regard to vascular risk factors. Migraineurs with WMLs had a longer disease duration (p < 0.001) and a higher number of lifetime headache attacks (p = 0.005) than lesion-free patients. Higher L-arginine serum levels were found in both migraine subgroups compared to controls (p < 0.001). Migraine patients with WMLs showed higher ADMA concentrations than lesion-free patients and controls (p < 0.001, for both). In migraineurs, the presence of WMLs, aura and increasing age proved to be significant predictors of increased ADMA levels (p = 0.008, 0.047 and 0.012, respectively). SDMA serum levels of lesional migraineurs were higher than in nonlesional patients (p < 0.001). The presence of lesions and increasing age indicated an increased SDMA level (p = 0.017 and 0.001, respectively). Binary logistic regression analysis showed that ADMA level (p = 0.006), increasing age (p = 0.017) and the total number of lifetime migraine attacks (p = 0.026) were associated with an increased likelihood of exhibiting WMLs. There was no significant effect of age on ADMA and SDMA concentrations in controls.CONCLUSIONS: Elevated ADMA levels may impact the pathogenesis of migraine-related WMLs by influencing cerebrovascular autoregulation and vasomotor reactivity. Higher SDMA concentrations may indirectly influence NO synthesis by reducing substrate availability. Elevated L-arginine serum levels might reflect an increased demand for NO synthesis.

U2 - 10.1177/0333102416651454

DO - 10.1177/0333102416651454

M3 - Journal article

C2 - 27206959

VL - 37

SP - 571

EP - 580

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 6

ER -

Erdélyi-Bótor S, Komáromy H, Kamson DO, Kovács N, Perlaki G, Orsi G et al. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions. Cephalalgia. 2017;37(6):571-580. https://doi.org/10.1177/0333102416651454